Author

Suming Pan

Institution: Yue Bei People's Hospital

Observed institution: Yue Bei People's Hospital

ORCID: 0000-0002-1942-3869

Observed ORCID: 0000-0002-1942-3869

OpenAlex ID: A5083206631

ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling

2021 · Suming Pan, Sixian Liang, et al. · Life Sciences · 25

DPCPX induces Bim‐dependent apoptosis in nasopharyngeal carcinoma cells

2022 · Suming Pan, Xiangguo Zhang, et al. · Cell Biology International · 3

Carboplatin-based versus cisplatin-based induction-concurrent chemoradiotherapy with locoregionally advanced nasopharyngeal carcinoma: A multicenter, parallel-group, non-inferiority, randomized, phase 3 trial.

2026 · Xiaoqing Wang, Min Chen, et al. · Journal of Clinical Oncology · 1

Cltr-09 Synergistic Effect Between Act001 and Wbrt/ici in Nsclc Patients With Brain Metastasis: the Interim Analysis of a Phase 2, Multi-center and Double-blind Rct Study

2026 · Linlin Wang, Hui Wang, et al. · Neuro-Oncology Advances

Works count: 4

Citation count: 29

H-index: 2

I10-index: 1